1 |
Estrada S, Elgland M, Selvaraju RK, Mani K, Tegler G, Wanhainen A, Wågsäter D, Bergström M, Jimenez-royo P, Jahan M, Nordeman P, Antoni G. Preclinical evaluation of [11C]GW457427 as a tracer for neutrophil elastase. Nuclear Medicine and Biology 2022;106-107:62-71. [DOI: 10.1016/j.nucmedbio.2022.01.001] [Reference Citation Analysis]
|
2 |
Jacenik D, Fichna J, Małecka-Wojciesko E, Mokrowiecka A. Protease-Activated Receptors - Key Regulators of Inflammatory Bowel Diseases Progression. J Inflamm Res 2021;14:7487-97. [PMID: 35002281 DOI: 10.2147/JIR.S335502] [Reference Citation Analysis]
|
3 |
Dudzińska E, Strachecka A, Gil-Kulik P, Kocki J, Bogucki J, Shemedyuk N, Gryzinska M. Influence of the Treatment Used in Inflammatory Bowel Disease on the Protease Activities. Int J Gen Med 2020;13:1633-42. [PMID: 33380821 DOI: 10.2147/IJGM.S267036] [Reference Citation Analysis]
|
4 |
Zhu Y, Huang Y, Ji Q, Fu S, Gu J, Tai N, Wang X. Interplay between Extracellular Matrix and Neutrophils in Diseases. J Immunol Res 2021;2021:8243378. [PMID: 34327245 DOI: 10.1155/2021/8243378] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
5 |
Craig CF, Filippone RT, Stavely R, Bornstein JC, Apostolopoulos V, Nurgali K. Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease. J Neuroinflammation 2022;19:4. [PMID: 34983592 DOI: 10.1186/s12974-021-02354-1] [Reference Citation Analysis]
|
6 |
Al Ojaimi Y, Blin T, Lamamy J, Gracia M, Pitiot A, Denevault-Sabourin C, Joubert N, Pouget JP, Gouilleux-Gruart V, Heuzé-Vourc'h N, Lanznaster D, Poty S, Sécher T. Therapeutic antibodies - natural and pathological barriers and strategies to overcome them. Pharmacol Ther 2021;:108022. [PMID: 34687769 DOI: 10.1016/j.pharmthera.2021.108022] [Reference Citation Analysis]
|